Publications and communications of Laura Vranken

Vranken, L., DIEUPE, G., & Cavalier, E. (13 November 2025). Comparison of three PEG precipitation protocols for the detection of macrovitamin B12 interference [Poster presentation]. Annual meeting of the Royal Society of Laboratory Medecine 2025.

Résimont, G., VRANKEN, L., Pottel, H., JOURET, F., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (27 June 2022). Estimating urine albumin to creatinine ratio from protein to creatinine ratio using same day measurement: validation of equations. Clinical Chemistry and Laboratory Medicine, 60 (7), 1064-1072. doi:10.1515/cclm-2022-0049

GREGOIRE, C.* , HUYNEN, P.* , Gofflot, S., Seidel, L., Maes, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (13 June 2022). Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12, 9790. doi:10.1038/s41598-022-13450-4
* These authors have contributed equally to this work.

HUYNEN, P.* , GREGOIRE, C.* , GOFFLOT, S., SEIDEL, L., MAES, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (25 March 2022). Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12 (1), 5156. doi:10.1038/s41598-022-09215-8
* These authors have contributed equally to this work.

Résimont, G., VRANKEN, L., CAVALIER, E., & DELANAYE, P. (2021). Estimation d’un ratio Albumine/Créatinine urinaire à partir d’un ratio Protéine/Créatinine urinaire au départ de mesures réalisées sur un même échantillon : validation d’équations [Paper presentation]. VI congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Toulouse, France.

DELANNOY, P., VRANKEN, L., CAVALIER, E., & VALDES SOCIN, H. G. (2020). Carence en vitamine B12 : diagnostic et prise en charge. Tempo Médical, 24-28.

Bjork, J., Nyman, U., DELANAYE, P., Grubb, A., Larsson, A., VRANKEN, L., Akesson, A., & Pottel, H. (2020). A novel method for creatinine adjustment makes the revised Lund-Malmö GFR estimating equation applicable in children. Scandinavian Journal of Clinical and Laboratory Investigation, 80 (6), 456-463. doi:10.1080/00365513.2020.1774641

VRANKEN, L., BERTHOLET, C., LUKAS, P., & CAVALIER, E. (15 November 2019). Comparison of two automated assays for the determination of cobalaminin serum [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

VRANKEN, L., FONTAINE, C., LUKAS, P., & CAVALIER, E. (15 November 2019). Unexpected high levels of Cobalamin (Vitamin B12). Is PEG treatment useful? [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

VRANKEN, L., FONTAINE, C., VALDES SOCIN, H. G., LUKAS, P., LE GOFF, C., Huyghebaert, L., & CAVALIER, E. (15 November 2019). Impact of Metformin on vitamin B12 status [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

VRANKEN, L., PIELTAIN, C., & CAVALIER, E. (15 November 2019). Evaluation of neonatal bilirubin method on GEM 5000 blood gas analyzer [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

DELANAYE, P., VRANKEN, L., Pottel, H., & CAVALIER, E. (2019). Impact du choix de l’équation basée sur la créatinine sur la classification de la maladie rénale chronique dans une base de données de laboratoire. Néphrologie et Thérapeutique.

DELANAYE, P., VRANKEN, L., Schoneveld, L., LAMBERMONT, B., & CAVALIER, E. (2019). Prévalence de l’atteinte rénale aigue chez le patient hospitalisé en fonction du critère de variation de la créatinine utilisée. Néphrologie et Thérapeutique.

BERTHOLET, C., Lamtiri-Laarif, M., VRANKEN, L., GADISSEUR, R., DELCOUR, S., & CAVALIER, E. (May 2019). Verification of the reference intervals proposed by Abbott on Alinity ci in a population of healthy subjects from Liege, Belgium [Poster presentation]. Euromedlab IFCC.

LADANG, A., BERTHOLET, C., VRANKEN, L., & CAVALIER, E. (May 2019). GLOBAL STRATEGY OF IMPLEMENTATION OF CALIPER PEDIATRIC REFERENCE VALUES IN A BELGIAN INSTITUTE [Poster presentation]. Euromedlab 2019.

ROUATBI, H., Gkiouki, E., Zigabe, S., VAN LINTHOUT, C., VRANKEN, L., & Seghaye, M.-C. (May 2019). Cardiac stress biomarkers in neonates: role of the delivery mode [Poster presentation]. 53rd Annual Meeting for European Paediatric and Congenital Cardiology, Séville, Spain.

VALDES SOCIN, H. G., VRANKEN, L., Schoneveld, L., DELANNOY, P., Le Goff, C., Beckers, A., & CAVALIER, E. (2019). Vitamin B12 deficiency prevalence and associated biomarkers in type 2 Diabetes (T2DM) treated with metformin : biochemical assessment in a series of 106 patients. In Endocrine Abstracts - ECE 2019.

VRANKEN, L., FONTAINE, C., LUKAS, P., & CAVALIER, E. (May 2019). Unexpected high levels of Cobalamin(Vitamin B12). Is PEG treatment a solution? [Poster presentation]. 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019.

VRANKEN, L., FONTAINE, C., LUKAS, P., LE GOFF, C., Huyghebaert, L., CAVALIER, E., & VALDES SOCIN, H. G. (May 2019). Evaluation of Metformin impact on vitamin B12 status [Poster presentation]. 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019, Barcelone, Spain.

Le Goff, C., Lennartz, L., VRANKEN, L., Kaux, J.-F., & Cavalier, E. (February 2019). Comparison of cardiac biomarker dynamics in marathon, semimarathon and untrained runners: what is the impact on results interpretation? Journal of Laboratory and Precision Medicine, 4 (6), 10. doi:10.21037/jlpm.2019.01.04

masson, G., VRANKEN, L., KRZESINSKI, J.-M., Pottel, H., CAVALIER, E., & DELANAYE, P. (2019). Impact of the creatinine-based equations used on the chronic kidney disease classification in a large laboratory database. Nephrology Dialysis Transplantation.

GADISSEUR, R., MUSSO, G., Cavalier, E., & VRANKEN, L. (Other coll.). (28 September 2018). Validation of 24 blood gas analyzers, GEM 5000 Premier [Poster presentation]. AACC POCT, washington, United States.

VRANKEN, L., EMONTS, P., Bruyère, O., & CAVALIER, E. (January 2018). Prévalence de l’hypovitaminose D chez la femme enceinte : quelle est la situation en région liégeoise ? Revue Médicale de Liège, 73 (1), 10-16.

LADANG, A., VRANKEN, L., & CAVALIER, E. (November 2017). Pediatric reference intervals: Retrospective study for 8 common chemistry parameters on Cobas c6000 analyzer (Roche°) [Poster presentation]. meeting annuel RBSLM.

Le Goff, C., VRANKEN, L., Kaux, J.-F., & Cavalier, E. (September 2017). Comparison of cardiac biomarkers fluctuation in runners of marathons, semi-marathons and untrained runners. European Journal of Sports Medicine, 5 (Supplement 1), 16.

LE GOFF, C., VRANKEN, L., van Nueten, J., Lennartz, L., & CAVALIER, E. (2017). Comparison of cardiac biomarker fluctuation in runners of marathons, semi-marathons and untrained runners. Clinical Chemistry and Laboratory Medicine.

LADANG, A., VRANKEN, L., LUYCKX, F., LEBRETHON, M.-C., & CAVALIER, E. (2017). Etude rétrospective du bilan thyroïdien: définition de valeurs de référence pédiatriques. Revue Médicale de Liège.

Winckert, A., VRANKEN, L., BOEMER, F., Courtois, J., & Cavalier, E. (2017). L'hypophosphatasie. Revue Médicale de Liège, 72 (12), 547-551.

LADANG, A., VRANKEN, L., & CAVALIER, E. (October 2016). Unexpected high levels of Cobalamin (Vitamin B12): Numerous interferences are decreased by PEG treatment [Poster presentation]. Congrès de la société belge de médecine de laboratoire.

VRANKEN, L., CAVALIER, E. (Other coll.), & VALDES SOCIN, H. G. (Other coll.). (01 March 2013). Holotranscobalamin versus Total Vitamin B12 as Indicators of Vitamin B12 deficiency in Thyrogastric Syndrome [Poster presentation]. Belgian week of gastroenterology, Anvers, Belgium.

CAVALIER, E., DELANAYE, P., Vranken, L., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & Souberbielle, J.-C. (28 July 2011). Impact of the use of the Manufacturer's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines [Poster presentation]. AACC, Atlanta, United States.

VROONEN, L., Cavalier, E., Vranken, L., VALDES SOCIN, H. G., PETROSSIANS, P., & Beckers, A. (2011). Influence of drospirenone on renin-angiotensin-aldosterone system evaluation. In Endocrine Abstracts - 13th European Congress of Endocrinology.

VROONEN, L., Cavalier, E., Vranken, L., VALDES SOCIN, H. G., PETROSSIANS, P., & Beckers, A. (2011). Drospirenone and interference with renin-antiotensin system. In Annales d'Endocrinologie - 28ème congrès de la société Française d'Endocrinologie.